Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients

Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients

Related Posts

The Fed is running into a wall of its own making ahead of next week’s interest-rate vote

The Fed is running into a wall of its own making ahead ...

Spirit Airlines scraps plan to furlough up to 365 pilots

Spirit Airlines scraps plan to furlough up to 365 pilots

Here’s how the best investors protect their money from market bubbles and FOMO

Here’s how the best investors protect their money from ...

Enanta Pharma CBO Luu sells $19,836 in stock

Enanta Pharma CBO Luu sells $19,836 in stock

Wall St closes with slight gains as data keeps Fed cut expectations on track

Wall St closes with slight gains as data keeps Fed cut ...

Adaptive Biotechnologies CSO Robins sells $672,515 in ADPT stock

Adaptive Biotechnologies CSO Robins sells $672,515 in A...